DNA Methylation in Glioblastoma and Its Effects on Gene Expression and Survival
Author Information
Author(s): Amandine Etcheverry, Marc Aubry, Marie de Tayrac, Elodie Vauleon, Rachel Boniface, Frederique Guenot, Stephan Saikali, Abderrahmane Hamlat, Laurent Riffaud, Philippe Menei, Veronique Quillien, Jean Mosser
Primary Institution: CNRS UMR6061 Institut de Génétique et Développement, Université de Rennes 1, UEB, IFR140, Rennes, France
Hypothesis
How does DNA methylation affect gene expression and clinical outcomes in glioblastoma patients?
Conclusion
The study identifies specific DNA methylation changes that correlate with gene expression and overall survival in glioblastoma patients.
Supporting Evidence
- 616 CpG sites were found to be differentially methylated between glioblastoma and control brain samples.
- Thirteen genes showed an inverse correlation between promoter methylation and expression levels.
- Six CpG sites were associated with overall survival in the patient cohort.
Takeaway
This study looks at how changes in DNA can affect how genes work in brain tumors, which might help doctors decide on treatments.
Methodology
The study involved a genome-wide analysis of DNA methylation and gene expression in glioblastoma patients, using tissue samples and various molecular techniques.
Potential Biases
Potential biases may arise from the selection of patients and the uniform treatment approach.
Limitations
The study's findings may not be generalizable due to the specific cohort and treatment protocols used.
Participant Demographics
The cohort included 55 newly diagnosed glioblastoma patients with a median age of 57.5 years.
Statistical Information
P-Value
< 5e-04
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website